# Wegovy and alcohol: can you drink on semaglutide? Canonical URL: https://www.hemed.com/blog/wegovy-and-alcohol Plain-text URL: https://www.hemed.com/blog/wegovy-and-alcohol/llms.txt Published: 2026-11-05 Modified: 2026-11-05 Author: The HeMed clinical team Topic: Weight-loss treatment Topic URL: https://www.hemed.com/blog/topic/weight-loss-treatment Tags: Wegovy, Nutrition, Side effects Reading time: 17 min Publisher: HeMed (https://www.hemed.com/) ## Summary Wegovy's licence sets no alcohol rule. The NHS says it is best not to drink: alcohol can add to nausea and vomiting. What men on treatment should know. ## Article The Wegovy (semaglutide) licence sets no rule on alcohol. The NHS advice is that it is best not to drink, because alcohol can increase side effects like feeling or being sick. If you do drink, the general advice for everyone applies: drink with food, drink slowly, alternate with water and stay within 14 units a week. A unit is 10 ml or 8 g of pure alcohol. Semaglutide is a GLP-1 receptor agonist: a medicine that acts on the receptors for GLP-1, a hormone that regulates appetite and calorie intake. A licence is a medicine’s UK approval. Its rules sit in the Summary of Product Characteristics (SmPC) and the patient leaflet, which the Medicines and Healthcare products Regulatory Agency (MHRA) approves. ### Can you drink alcohol on Wegovy? Nothing in the licence bans alcohol. The Wegovy SmPC carries no alcohol warning, interaction or precaution. The patient leaflet does not mention alcohol at all. A contraindication is a reason a medicine must not be used. The only one for Wegovy is an allergy to semaglutide or one of its ingredients. The NHS medicine page for semaglutide takes a cautious line. It says it is best not to drink alcohol, “because it can increase side effects like feeling or being sick (nausea or vomiting)”. That page covers Wegovy together with the other semaglutide brands, so the advice applies to the medicine rather than to one product. So the position is simple. The licence does not ban alcohol, and the NHS advises against it. The reasons are about side effects rather than a listed interaction, and the rest of this article explains them. ### Does Wegovy change how your body handles alcohol? The licence reports no study of semaglutide taken with alcohol. It lists no interaction between the two. So nothing in the licence says a drink affects you more, or less, on Wegovy. The licence does say that semaglutide may delay stomach emptying. It adds that no clinically relevant effect on the rate of gastric emptying was observed with the 2.4 mg dose. A delay in stomach emptying is listed as an uncommon side effect, meaning 1 in 1,000 to 1 in 100 people. #### Two general facts about alcohol Two facts about alcohol apply to everyone. Food slows absorption: with a meal, blood alcohol may stay below a quarter of the level reached on an empty stomach. On an empty stomach, blood alcohol peaks about an hour after drinking, depending on the amount. The same amount of alcohol can produce very different blood levels in different people. Body size, build and the share of water and fat in the body all play a part. Wegovy works by reducing your appetite. Whatever your appetite is doing, drink with food. ### Which side effects can alcohol add to? The NHS names nausea and vomiting, and the licence warns about dehydration. All three are most likely while your dose is still being increased. Blood sugar is a separate question that mainly concerns men with type 2 diabetes. #### Nausea, vomiting and diarrhoea Nausea, vomiting, diarrhoea, constipation, stomach pain, headache and tiredness are very common side effects of semaglutide. Very common means more than 1 in 10 people. They are mainly seen in the dose-escalation period, the 16 weeks over which the dose builds to 2.4 mg. Most events were mild to moderate and of short duration. Constipation lasted longer. In the phase 3 trials, the large trials run before approval, nausea affected 43.9% of people on semaglutide 2.4 mg over 68 weeks. The figure was 16.1% on placebo, a dummy treatment used for comparison. Vomiting affected 24.5% on semaglutide against 6.3% on placebo. Average trial results are not a prediction of individual results. Alcohol can increase these effects. The NHS gives that as its reason for advising against drinking. The MHRA says gastrointestinal effects, meaning stomach and gut effects, are more likely at the start of treatment or after a recent dose increase. They can persist for several days. If gastrointestinal symptoms are significant, the licence lets your prescriber delay a dose increase or go back to the previous dose. #### Dehydration Nausea, vomiting and diarrhoea can cause dehydration. In rare cases that can lead to a deterioration in kidney function. The licence says patients should be told about this risk and take precautions to avoid fluid depletion. The MHRA’s advice is to stay well hydrated throughout treatment by drinking plenty of fluids, such as water. Alcohol pulls in the other direction. The kidneys pass more urine after a drink, partly because alcohol suppresses the hormone that holds water back. The NHS lists drinking too much alcohol among the causes of dehydration. It also says to avoid alcohol when you are already dehydrated. Keep the size of alcohol’s diuretic effect in proportion. A diuretic effect means passing more urine. In a controlled trial in older men, moderate amounts of wine or spirits had a short and small diuretic effect. Beer at 5% had none. The point is not that one drink will dehydrate you. It is that vomiting, diarrhoea and alcohol all push the same way. #### Blood sugar Semaglutide lowers blood glucose and can cause hypoglycaemia, which is low blood sugar. In people without type 2 diabetes this is uncommon, meaning 1 in 1,000 to 1 in 100. The risk rises if you also take insulin or a sulfonylurea, a type of diabetes tablet. Alcohol can lower blood sugar too. When the liver is processing alcohol it makes less glucose, so blood sugar can fall. Diabetes UK says drinking makes a hypo, a low blood sugar episode, more likely if you use insulin or a sulfonylurea. The risk is higher still on an empty stomach, and it can last up to 24 hours. A hypo can also be mistaken for being drunk. For people without diabetes in general, the NHS says low blood sugar is rare. The licence still asks everyone on semaglutide to know the signs: cold sweat, shaking, a fast heartbeat, hunger, confusion and feeling weak. If you have type 2 diabetes, ask your diabetes team about alcohol before you drink on treatment. ### What is the pancreatitis risk? Acute pancreatitis is a sudden inflammation of the pancreas. It is an uncommon side effect of semaglutide: 1 in 1,000 to 1 in 100 people. In the phase 3 trials, confirmed cases were 0.2% on semaglutide 2.4 mg and under 0.1% on placebo. Drinking a lot of alcohol is one of the two most common causes of acute pancreatitis in general, alongside gallstones. None of the sources in this article puts a number on the two risks together. Treat them as two separate reasons for care rather than one combined figure. #### What the regulator says The MHRA strengthened its pancreatitis warning for this class of medicines in January 2026. It says the overall frequency remains uncommon. Some rare reports have been particularly severe, including fatal cases and necrotising cases, where part of the pancreas dies. Semaglutide has not been studied in people with a history of pancreatitis and should be used with caution in them. The MHRA also notes that early pancreatitis can be hard to spot. Its first signs can look like ordinary gastrointestinal side effects. #### The sign to act on Severe and persistent pain in the stomach area is the sign to act on. It may come with or without nausea and vomiting, and it may spread to your back. The leaflet says to stop the medicine and seek urgent medical help. If you have had pancreatitis, the NHS lists it as a reason the medicine may not be suitable. After an episode, the NHS advises drinking less alcohol or none at all. ### What does the research on drinking show? The one human trial used the two lowest clinical doses, not the 2.4 mg weight-management dose. It reported less craving and less drinking on some measures in adults with alcohol use disorder. Wegovy is not licensed for alcohol use disorder. Alcohol use disorder is the clinical term for harmful or dependent drinking. Any effect on drinking is a research finding, not a treatment benefit. The research is early, and its findings do not carry over to weight-management doses. #### What the one trial found The best human evidence is one small trial. In a trial published in 2025, Hendershot and colleagues randomised 48 adults with alcohol use disorder to low-dose semaglutide or placebo for 9 weeks. Only 14 of the 48 were men. The doses were 0.25 mg and then 0.5 mg a week, with an optional 1.0 mg in the final week. In that trial, semaglutide reduced weekly craving and drinks per drinking day. People also drank less in a laboratory session, but the number of drinking days did not change. The authors call this initial evidence and note the modest sample size and short treatment. They also point out that they used the two lowest clinical doses, while doses for weight reduction reach 2.4 mg a week. #### What the records studies show Two records studies add association rather than cause. In US veterans’ health records, people prescribed GLP-1 receptor agonists reported bigger falls in a drinking questionnaire score than comparison groups. Over 90% of that group was male. One records study of 83,825 patients with obesity compared semaglutide with other weight-loss medicines. It linked semaglutide to a 50% to 56% lower rate of alcohol use disorder diagnoses over 12 months. Records studies show association rather than cause, and a lower rate of recorded diagnoses is not a measured change in drinking. None of this changes the advice above. Nothing in it shows that Wegovy changes drinking at the 2.4 mg dose. If your drinking changes on treatment in either direction, tell your clinician. ### What are sensible precautions if you drink? Drink with food, drink slowly, alternate with water and keep the total down. That is the UK Chief Medical Officers’ advice for any single occasion. It applies to everyone, on treatment or not. Six practical points follow from the sources in this article. #### Before and while you drink - Eat before you drink, and drink with food. Food slows alcohol absorption and lowers the peak. This applies whatever your appetite is doing. - Drink slowly and keep the total down. Peak blood alcohol is higher when the same amount is drunk in one go rather than spread out. More than 8 units in one session counts as binge drinking for men. - Alternate with water. A glass of water between drinks helps you pace yourself and avoid the dehydrating effects of alcohol. On treatment, the licence already asks you to avoid fluid depletion. #### Across the week and on treatment - Stay within 14 units a week, spread over 3 or more days. That is the low-risk guideline for men and women. One or two heavy episodes a week raise your risks of death from long-term illness and from accidents and injuries. The NHS puts 14 units at about 6 pints of average-strength beer or 10 small glasses of lower-strength wine. - Expect side effects to be most likely early on. Gastrointestinal effects cluster during dose escalation and after each dose increase. Neither the leaflet nor the NHS sets a waiting time after an injection, so those are the weeks to be most careful. - Tell your clinician how much you drink. Alcohol is part of your health picture, and your clinician can only advise on it with accurate information. Ask before you drink if anything in this article worries you. One more line from the NHS is worth keeping in mind. It calls 14 units “low risk” rather than “safe” because there is no safe drinking level. ### What does alcohol do to your liver? Regularly drinking too much alcohol damages the liver over months or years, and the early stages often cause no symptoms. The NHS says alcohol-related liver disease is more likely if you drink too much and are also overweight or have type 2 diabetes. If you stop drinking, the liver can often recover. #### What liver blood tests show Alcohol can show in liver blood tests. ALT (alanine aminotransferase) is an enzyme that leaks into the blood when liver cells are under strain. A moderately high ALT can occur with high alcohol intake. GGT (gamma-glutamyl transferase) is an enzyme that rises with liver stress, including from alcohol. In regular drinkers, alcohol in the previous 24 hours can raise GGT for a short time. AST (aspartate aminotransferase) is a second liver enzyme, read alongside ALT. Blood tests are one of the ways the NHS checks for alcohol-related liver disease, along with scans and sometimes a biopsy. If you are worried about your drinking or your liver, the NHS says to get medical help. Do not wait for symptoms to get worse. If you regularly drink heavily, it can be dangerous to stop suddenly. Get medical help before you try. ### How does HeMed fit in? HeMed starts with a blood test. We measure 10 metabolic markers across four systems from a needle-free blood test at home. Liver function: ALT, AST and GGT. A clinician reviews your blood test first. If they approve treatment, we deliver it the next working day, discreetly packaged, with delivery included in your plan. A weekly in-app check-in, reviewed by clinicians, so your plan can be adjusted when it needs to be. A retest every 6 months shows what’s actually changing. Wegovy is a prescription medicine for weight management. Whether it’s right for you is a clinical decision, made from your health information and your baseline blood test. ### When should you seek medical help? Some symptoms should not wait. The NHS says to call 111 if you are taking semaglutide and think you might be having serious side effects. The signs below come from the leaflet, the MHRA and the NHS. #### Pain, vomiting and dehydration - Severe and persistent pain in the stomach area, with or without nausea and vomiting. Stop the medicine and seek urgent medical help, because this can be a sign of acute pancreatitis. Call 999 or go to A&E if sudden severe pain is spreading to your back, or comes with a fast heartbeat or difficulty breathing. - Signs of dehydration that do not settle. These include dark yellow pee, peeing less than usual, dizziness on standing that does not go away, unusual tiredness or a fast heart rate. Ask for an urgent GP appointment or call 111. Call 999 if someone is confused, hard to wake, has cold or blotchy skin or has difficulty breathing. - Vomiting you cannot control. Guy’s and St Thomas’ NHS trust gives four reasons for people on weight-loss medicines to contact their healthcare team or a GP. They are vomiting more than 3 times a day, not keeping fluids down, dark pee and feeling lightheaded. #### Low blood sugar and jaundice - Signs of low blood sugar: cold sweat, shaking, a fast heartbeat, sudden hunger or confusion. Call 999 if someone with very low blood sugar is not responding normally and has been drinking alcohol. If you do not have diabetes and get these symptoms, see a GP. - Yellowing of the skin or the whites of your eyes (jaundice). The leaflet lists it as a sign of raised bilirubin, an uncommon side effect. Bilirubin is a yellow pigment in the blood. The NHS lists it as a sign of worsening alcohol-related liver damage. Either way, get medical advice. ### Frequently asked questions **Can I drink alcohol while taking Wegovy?** The licence sets no rule on alcohol. The SmPC has no alcohol warning and the leaflet does not mention it. The NHS says it is best not to drink, because alcohol can increase side effects like feeling or being sick. If you do drink, eat first, drink slowly and keep water alongside. Stay within 14 units a week, spread over 3 or more days. Tell your clinician how much you drink. **Does alcohol make Wegovy side effects worse?** It can. The NHS says alcohol can increase side effects like nausea and vomiting. Those effects are very common with semaglutide and cluster while the dose is being increased. Vomiting and diarrhoea can dehydrate you, and alcohol adds to that. Drink plenty of water, and avoid alcohol altogether while you are being sick. **Does alcohol affect you differently on Wegovy?** The licence reports no study of semaglutide taken with alcohol and lists no interaction. It also reports no clinically relevant effect on the rate of stomach emptying at the 2.4 mg dose. Drinking on an empty stomach gives a faster and higher peak than drinking with food. Body size and build also change the level a drink produces. Drink with food, whatever your appetite. **Do you need to wait after your weekly dose before drinking?** Neither the leaflet nor the NHS sets a waiting time after an injection. Half-life is the time the body takes to clear half a dose. For semaglutide it is about a week, so the medicine is in your body all week. It is still present around 7 weeks after a last dose. Side effects are most likely at the start of treatment and after each dose increase. Those are the weeks to be most careful with alcohol. **Is there a pancreatitis risk from drinking on Wegovy?** Acute pancreatitis is an uncommon side effect of semaglutide, affecting between 1 in 1,000 and 1 in 100 people. Drinking a lot of alcohol is one of the two most common causes of acute pancreatitis in general. No source puts a number on the two together. Severe and persistent pain in the stomach area needs urgent medical help, and the leaflet says to stop the medicine. If you have had pancreatitis before, tell your clinician. The licence says semaglutide should be used with caution in that case. **What does the research say about alcohol cravings?** The one human trial did not use the weight-management dose. It gave 48 adults with alcohol use disorder up to 1.0 mg a week for 9 weeks. It reported less craving and less drinking on some measures. Two records studies linked GLP-1 receptor agonists, or semaglutide, with lower drinking scores or fewer alcohol use disorder diagnoses, but association is not cause. Wegovy is not licensed for alcohol use disorder. If your drinking changes on treatment, tell your clinician. **How does alcohol affect liver blood tests?** A moderately high ALT can occur with high alcohol intake, and alcohol in the previous 24 hours can raise GGT for a short time. Alcohol-related liver disease develops over months or years of drinking too much, and it often has no early symptoms. The HeMed blood test measures 10 markers across four systems. Liver function: ALT, AST and GGT. A blood test alone does not diagnose or stage liver disease. HeMed provides clinician-led weight management. Treatment is prescription-only and is prescribed only where a clinician decides it is suitable. This page is general health information, not medical advice. If you are worried about symptoms, speak to your GP, or use NHS 111. Next step: see what the HeMed blood test measures. Sources (21) - Novo Nordisk, Wegovy FlexTouch (semaglutide) Summary of Product Characteristics, sections 4.1 to 4.8, 5.1 and 5.2 (text revised September 2026). electronic medicines compendium. medicines.org.uk/emc/product/13800/smpc. Accessed 5 November 2026. - Novo Nordisk, Wegovy FlexTouch Patient Information Leaflet, sections 2 and 4 (last revised August 2026). electronic medicines compendium. medicines.org.uk/emc/product/13800/pil. Accessed 5 November 2026. - NHS, “Semaglutide: a medicine to manage type 2 diabetes or treat obesity”, sections on food, drink and alcohol, side effects and who can use it (page last reviewed 15 May 2026). nhs.uk/medicines/semaglutide. Accessed 5 November 2026. - NHS, “The risks of drinking too much” (page last reviewed 10 September 2026). nhs.uk/live-well/alcohol-advice/the-risks-of-drinking-too-much. Accessed 5 November 2026. - NHS, “Calculating alcohol units” (page last reviewed 27 August 2024). nhs.uk/live-well/alcohol-advice/calculating-alcohol-units. Accessed 5 November 2026. - Paton A, “Alcohol in the body”, BMJ 2005;330(7482):85 to 87. doi.org/10.1136/bmj.330.7482.85. Accessed 5 November 2026. - Cederbaum AI, “Alcohol metabolism”, Clinics in Liver Disease 2012;16(4):667 to 685. doi.org/10.1016/j.cld.2012.08.002. Accessed 5 November 2026. - MHRA, “GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse”, Drug Safety Update, 24 October 2024. gov.uk/drug-safety-update. Accessed 5 November 2026. - NHS, “Dehydration” (page last reviewed 1 May 2026). nhs.uk/conditions/dehydration. Accessed 5 November 2026. - Polhuis KCMM et al., “The diuretic action of weak and strong alcoholic beverages in elderly men: a randomized diet-controlled crossover trial”, Nutrients 2017;9(7):660. doi.org/10.3390/nu9070660. Accessed 5 November 2026. - Diabetes UK, “Alcohol and diabetes” (content last reviewed 17 December 2024). diabetes.org.uk. Accessed 5 November 2026. - NHS, “Low blood sugar (hypoglycaemia)” (page last reviewed 3 August 2023). nhs.uk/conditions/low-blood-sugar-hypoglycaemia. Accessed 5 November 2026. - NHS, “Acute pancreatitis” (page last reviewed 11 March 2026). nhs.uk/conditions/acute-pancreatitis. Accessed 5 November 2026. - MHRA, “GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including necrotising and fatal cases”, Drug Safety Update, 29 January 2026. gov.uk/drug-safety-update. Accessed 5 November 2026. - Hendershot CS et al., “Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial”, JAMA Psychiatry 2025;82(4):395 to 405 (published online 12 February 2025). doi.org/10.1001/jamapsychiatry.2024.4789. Accessed 5 November 2026. - Farokhnia M et al., “Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake”, Journal of Clinical Investigation 2025;135(9):e188314. doi.org/10.1172/JCI188314. Accessed 5 November 2026. - Wang W et al., “Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population”, Nature Communications 2024;15:4548. doi.org/10.1038/s41467-024-48780-6. Accessed 5 November 2026. - UK Chief Medical Officers, “UK Chief Medical Officers’ Low Risk Drinking Guidelines”, August 2016, pages 4 to 6. assets.publishing.service.gov.uk (PDF). Accessed 5 November 2026. - NHS, “Alcohol-related liver disease (ARLD)” (page last reviewed 15 July 2026). nhs.uk/conditions/alcohol-related-liver-disease-arld. Accessed 5 November 2026. - Lab Tests Online UK, “Alanine aminotransferase (ALT) test” and “Gamma-glutamyl transferase (GGT) test”. labtestsonline.org.uk/tests/alanine-aminotransferase-alt-test and labtestsonline.org.uk/tests/gamma-glutamyl-transferase-ggt-test. Accessed 5 November 2026. - Guy’s and St Thomas’ NHS Foundation Trust, “Lifestyle advice for people taking weight loss medicines: managing side effects with diet”, section “When to get help” (last reviewed August 2025). guysandstthomas.nhs.uk/health-information. Accessed 5 November 2026. Numbered markers in the page text link to these entries. Statistics describe populations, not any one person’s results. Published 5 November 2026. --- This is the plain-text version of the article at https://www.hemed.com/blog/wegovy-and-alcohol, generated from the page on 2026-11-06. It is for information only and is not medical advice. Whether any treatment is right for a person is a clinical decision. Statistics describe populations, not any one person's results.